Samsung's Galaxy Ring has become the first smart ring on the market cleared by the U.S. Food and Drug Administration to screen for signs of obstructive sleep apnea, the company announced this week, extending a capability it first brought to the Galaxy Watch line in 2024.
The upgraded feature went live on the Galaxy Ring following a 510(k) clearance the FDA granted in July 2026, along with a parallel approval from South Korea's Ministry of Food and Drug Safety. Samsung says it is now the first company to bring FDA-cleared, over-the-counter sleep apnea risk detection to a ring-form wearable, available to adults 18 and older who have not previously been diagnosed with the condition.
How It Works
The feature runs its analysis using just two nights of monitoring. An onboard algorithm tracks blood oxygen saturation and motion throughout sleep and reports a count of breathing disruptions detected per hour — a proxy for the apnea-hypopnea index clinicians use to grade severity during an in-lab or home sleep study. Samsung designed the tool to run passively, without requiring a physician's order or oversight, through the Samsung Health app.
In the validation data Samsung submitted to support the clearance, the ring correctly identified 155 of 199 people with confirmed moderate-to-severe obstructive sleep apnea, a sensitivity of about 77.9%. It also correctly cleared 259 of 270 people who did not have the condition, a specificity of roughly 95.9%. Those figures put the ring in range of — though not equivalent to — a diagnostic home sleep test, which is the framing Samsung and the FDA have both been careful to maintain: this is a screening signal, not a diagnosis.
Why a Ring, and Why Now
Samsung's original Galaxy Watch sleep apnea feature received FDA De Novo authorization in February 2024, creating a new regulatory category for wearable-based OSA detection. Bringing the same underlying detection method to a ring is a smaller regulatory step — the Galaxy Ring submission reportedly went through as a follow-on 510(k) rather than a fresh De Novo pathway — but it matters clinically because rings solve an adherence problem watches don't. A ring is lighter, cheaper to run overnight without charging anxiety, and easier for people to simply forget they're wearing, which matters for a measurement that depends on someone actually keeping the device on through the night.
Obstructive sleep apnea affects an estimated 30 million adults in the U.S., and the American Academy of Sleep Medicine has long noted that a large majority go undiagnosed, often for years, because an in-lab polysomnogram remains the diagnostic gold standard and isn't something most people schedule casually. Consumer wearables have been angling to close that gap by functioning as a low-friction nudge toward formal testing rather than a replacement for it.
What This Means for Patients
A positive flag from the Galaxy Ring or Watch is not a sleep apnea diagnosis, and Samsung's own materials are explicit that the feature cannot replace a clinical sleep study. What it can do is give the roughly two-thirds of people with moderate-to-severe OSA who remain undiagnosed a concrete, personalized reason to see a doctor — something a generic symptom checklist rarely accomplishes. The sensitivity data suggests the ring will miss some true cases, so a negative result on a device like this shouldn't be read as reassurance if snoring, witnessed pauses in breathing, or persistent daytime sleepiness are already present. For people without a diagnosis who are on the fence about whether their sleep is worth investigating, an overnight check that requires no appointment and no referral lowers the barrier to finding out.